Literature DB >> 2578150

Recognition and display of the predominant idiotype among members of the regulatory circuitry controlling the anti-lysozyme immune response.

B A Araneo, R L Yowell, E E Sercarz.   

Abstract

The in vitro suppression of lysozyme (HEL)-primed helper T cell function (AgTh) is dependent on both suppressor inducer T cells (Tsi) (bearing the Lyt-1 and I-J surface antigens) and suppressor effector T cells (Tse) (bearing the Lyt-2 and I-A cell surface antigens). The AgTh and Tsi appear in draining lymph nodes of antigen-primed mice within 10 days of footpad immunization, whereas the Tse is detected in the lymph node around 21 days. Tse are localized to the spleen after i.p. immunization and represent the predominant functional T cell subset. In an attempt to understand the idiotypic relationships that exist among the three T cell types associated with anti-HEL responses in genetic low responder mice, each subset was characterized for expression of the predominant idiotype of anti-lysozyme antibodies, IdXL, by treatment with a cytotoxic anti-IdXL antibody and for IdXL-specificity by binding to IdXL-coated plates. Only the Tse was found to bear IdXL. The Tsi, on the other hand, binds to IdXL, and the AgTh belongs to a distinct idiotypic universe. These results suggest that the mode of communication between the Tsi and Tse is via idiotypic complementarity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578150

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen.

Authors:  I S Grewal; K D Moudgil; E E Sercarz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 2.  Immune suppression genes.

Authors:  D B Oliveira; N A Mitchison
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.